| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/07/2005 | US20050147676 Release sustaining composition and sustained release preparation |
| 07/07/2005 | US20050147674 A tablet or capsule prepared from a mixture of crystalline escitalopram oxalate having a median particle size of > 40 mu m and excipients; large particle size for use in direct compression; controlled crystallization from solution to avoid granulation and drying steps; binder-and lactose-free |
| 07/07/2005 | US20050147673 Directly compressible sustained release formulation containing microcrystalline cellulose |
| 07/07/2005 | US20050147672 Tablets quickly disintegrating in mouth |
| 07/07/2005 | US20050147671 A fast-release dosage of diclofenac or diclofenzc salts in the form of a packet of powder for dissolving or suspending in water or a high-speed release layer in a bilayered tablet that comprises a fast and a slow layer; palatable and free from aftertaste and side effects; consistancy; uniformity |
| 07/07/2005 | US20050147670 Oral disintegrating dosage forms |
| 07/07/2005 | US20050147669 Rapid dissolution formulation of a calcium receptor-active compound |
| 07/07/2005 | US20050147668 An orally-administered drug having low solubility in acid environment, e.g. stomach, being a powder contacted with water to form particules where >50% pass through sieve 180 mu m; in 0.07 N hydrochloric acid >50% released within 20 min.; high strength tablets; bioavailability; drug delivery |
| 07/07/2005 | US20050147667 Shaping a pill in a shape corresponding to the shape of the organ or body part it is intended to treat; substantially fool-proof ensuring identification unambiguously of the prescribed drug |
| 07/07/2005 | US20050147666 Rapidly disintegrates in the oral cavity without water and has a practical hardness; comprises a water soluble active ingredient, D-mannitol in the form of crystals or fine particles and crospovidone |
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/07/2005 | US20050147664 Comprising one or more nanoparticulate active agents, at least one PEG-derivatized surface stabilizer, and at least one antibody or fragment thereof; active agents preferably have a particle size of about 2 microns or less; for targeting delivery of the active agents to a desired site |
| 07/07/2005 | US20050147663 Drug dosage form containing active material and disintegrant in core covered with protective , swellable and enteric coatings |
| 07/07/2005 | US20050147661 Gelatin derivatives and high-molecular micelle comprising the derivatives |
| 07/07/2005 | US20050147660 Peptide-carrying bodies for immune response |
| 07/07/2005 | US20050147659 Oil/water/oil double microemulsion incorporated into solid support constituted by microporous inorganic substance or by an adsorbent colloidal inorganic substance or cross-linked swellable in water polymer, wherein drug is dissolved or dispersed in one or more phases of microemulsion; improved solubility |
| 07/07/2005 | US20050147658 Adhesive layer with backings; water erodible drug delivery device |
| 07/07/2005 | US20050147654 Method and device for topical delivery of therapeutic agents to the skin |
| 07/07/2005 | US20050147653 Quickly soluble film preparations |
| 07/07/2005 | US20050147626 administering clostridium to nerves for treatment of epilepsy and pain |
| 07/07/2005 | US20050147623 Recombinant parainfluenza virus expression systems and vaccines |
| 07/07/2005 | US20050147617 conjugates of methoxylpolyethylene glycol-glutamic acid oligopeptide and drug such as antitumor agents, having low toxicity, improved solubility, sustain and/or control release profiles |
| 07/07/2005 | US20050147595 Such as calcium crosslinked alginate containing pancreatic islets; free of adventitious excipients; do not dissolve in media or intraperitoneal cavity; durable, nontoxic transplant materials; diabetes |
| 07/07/2005 | US20050147594 Providing living cells enclosed within a bead, covering beaded cells with a semi-permeable layer made of a N-5-azido-2-nitrobenzoyloxysuccinimide crosslinked polylysine to obtain a product, photoactivating crosslinking agent to covalently link semipermeable layer to bead and biocompatible layer |
| 07/07/2005 | US20050147593 Targeting cells expressing low molecular weight protein tyrosine kinase (LMW-PTP) utilizing nucleic acid operatively associated with delivery vehicle |
| 07/07/2005 | US20050147589 Compositions for delivering biologically active drug and method of using the same |
| 07/07/2005 | US20050147588 Reducing body fat utilizing interferon tau |
| 07/07/2005 | US20050147583 Carbamylation to form a water soluble prodrug that has a biologically active agent linked to a water soluble non-immunogenic polymer; a hydrolyzing through carbamate bond; drug delivery; no enzymes or catalysts needed for release of acitve agent |
| 07/07/2005 | US20050147581 Molar ratio of acidic polymer to protein therapeutic in excess of stoichiometric requirement; such as pulmonary delivery of somatropin |
| 07/07/2005 | US20050147580 Therapy for kidney diseasel removal phosphates; gastrointestinal disorders |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | US20050147566 drugs delivery of different particle size drugs packaged for coadministration to the respiratory systems, using inhalnts |
| 07/07/2005 | US20050147565 using inhalants containing aerosol suspensions comprising mometasone furoate, formoterol fumarate and 1,1,1,2,3,3,3,-heptafluoropropane |
| 07/07/2005 | US20050147564 Inhalable formulation of a solution containing a tiotropium salt |
| 07/07/2005 | US20050147559 Internal drug dispenser capsule medical device |
| 07/07/2005 | DE10392718T5 Pharmazeutische Formulierung in einem Medikamentenfreisetzungssystem und Verfahren zur Herstellung derselben A pharmaceutical formulation in a drug release system and method for manufacturing the same |
| 07/07/2005 | DE10358747A1 Darreichungsform basierend auf vernetzten hydrophilen Polymeren Dosage form based on crosslinked hydrophilic polymers |
| 07/07/2005 | DE10358525A1 Endoparasitizide Mittel zur topischen Applikation Endoparasiticidal compositions for topical application |
| 07/07/2005 | DE10358387A1 Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung Powder containing low molecular weight dextran, and processes for their preparation |
| 07/07/2005 | DE10354894A1 Orale Formulierungen des Desoxypeganins und deren Anwendungen Oral formulations of deoxypeganine and their applications |
| 07/07/2005 | DE102004059530A1 Verfahren und Vorrichtung zur Herstellung eines Salzaerosols Method and apparatus for producing a salt aerosol |
| 07/07/2005 | CA2551183A1 Process for producing pellets for pharmaceutical compositions |
| 07/07/2005 | CA2550071A1 Pharmaceutical compositions |
| 07/07/2005 | CA2549966A1 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 07/07/2005 | CA2548408A1 Cefdinir oral suspension |
| 07/07/2005 | CA2545962A1 Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
| 07/07/2005 | CA2545961A1 Film-forming starchy composition |
| 07/07/2005 | CA2545947A1 Ophthalmic compositions containing a polysaccharide/borate gelling system |
| 07/07/2005 | CA2539169A1 A novel cationic lipopolymer as a biocompatible gene delivery agent |
| 07/06/2005 | EP1550719A1 Methods and medicament for inhibition the expression of a defined gene |
| 07/06/2005 | EP1550680A1 Biodegradable copolymer, and polymeric micelle composition containing the same |
| 07/06/2005 | EP1550675A1 Phospholipid derivative |
| 07/06/2005 | EP1550471A1 Intraocular implants for preventing transplant rejection in the eye |
| 07/06/2005 | EP1550458A1 Synergistic liposomal adjuvants |
| 07/06/2005 | EP1550453A1 Cancer antigen peptide preparation |
| 07/06/2005 | EP1550444A1 Controlled releases system containing temozolomide |
| 07/06/2005 | EP1550440A1 Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia |
| 07/06/2005 | EP1550439A1 Method for preparing a solid dosage form of desmopressin |
| 07/06/2005 | EP1550438A2 Method for preparing a medicated candy containing ambroxol and the thus obtained candy |
| 07/06/2005 | EP1549851A2 Electroactive polymer actuated medication infusion pumps |
| 07/06/2005 | EP1549633A1 Nicotine-containing, controlled release composition and method |
| 07/06/2005 | EP1549616A1 Organic acid salt of amlodipine |
| 07/06/2005 | EP1549394A2 Cardiovascular anchoring device and method of deploying same |
| 07/06/2005 | EP1549371A2 Nebulizer having a solvent and an inert substrate impregnated with a pharmaceutical ingredient |
| 07/06/2005 | EP1549366A1 Programmable dose control module |
| 07/06/2005 | EP1549355A2 Method, compounds and preparations for the identification of sentinel lymph nodes |
| 07/06/2005 | EP1549352A2 Methods for delivery of nucleic acids |
| 07/06/2005 | EP1549349A1 Non-viral gene delivery system |
| 07/06/2005 | EP1549337A1 Glycosaminoglycan-dnase combination therapy |
| 07/06/2005 | EP1549327A1 Composition for treating hemorrhoids |
| 07/06/2005 | EP1549326A1 Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin |
| 07/06/2005 | EP1549322A2 Lipid a and other carbohydrate ligand analogs |
| 07/06/2005 | EP1549311A1 Potent inhibitor of hcv serine protease |
| 07/06/2005 | EP1549299A2 Reduction of gelatin cross-linking |
| 07/06/2005 | EP1549298A1 Spheroids, preparation method thereof and pharmaceutical compositions |
| 07/06/2005 | EP1549297A2 Stabilized pharmaceutical composition containing basic excipients |
| 07/06/2005 | EP1549296A1 Sustained release formulations of metformin |
| 07/06/2005 | EP1549295A2 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 07/06/2005 | EP1549294A1 Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof |
| 07/06/2005 | EP1549293A1 Accelerating recovery from trauma |
| 07/06/2005 | EP1549292A2 Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration |
| 07/06/2005 | EP1549291A1 Injection formulation |
| 07/06/2005 | EP1549290A1 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 07/06/2005 | EP1549289A1 Effervescent formulations of oxytocin |
| 07/06/2005 | EP1549288A1 Nasallly applicable pharmaceutical preparation and the production thereof |
| 07/06/2005 | EP1549269A2 Cyclodextrin-based materials, compositions and uses related thereto |
| 07/06/2005 | EP1549265A1 Prosthetic foot with tunable performance |
| 07/06/2005 | EP1549246A2 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 07/06/2005 | EP1549242A2 Implantable sensor method and system |
| 07/06/2005 | EP1549159A2 Beverages containing plant sterols |
| 07/06/2005 | EP1549143A2 Antibacterial pyrazole carboxylic acid hydrazides |
| 07/06/2005 | EP1478338B1 Powder inhalation containing cgrp-antagonist bibn4096 and method for the production thereof |
| 07/06/2005 | EP1307188A4 Cannabinoid drugs |
| 07/06/2005 | EP1220662B1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 07/06/2005 | EP1140145B1 Novel exendin agonist formulations and methods of administration thereof |
| 07/06/2005 | EP1117379B1 Foamable formulation and foam |
| 07/06/2005 | CN2707266Y Medical plaster |
| 07/06/2005 | CN2707265Y Externally applied slow-released solution capsule |
| 07/06/2005 | CN2707264Y Navel therapy plaster for treating diabetes mellitus |
| 07/06/2005 | CN1636021A Preparation and use of solidified oils |